These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1993 related items for PubMed ID: 29763648

  • 1. Autism Spectrum Disorder: Classification, diagnosis and therapy.
    Sharma SR, Gonda X, Tarazi FI.
    Pharmacol Ther; 2018 Oct; 190():91-104. PubMed ID: 29763648
    [Abstract] [Full Text] [Related]

  • 2.
    Hosseini SA, Molla M.
    ; 2024 01. PubMed ID: 32491480
    [Abstract] [Full Text] [Related]

  • 3. Implications of comorbid ADHD in ASD interventions and outcome: Results from a naturalistic follow up study from south India.
    Manohar H, Kuppili PP, Kandasamy P, Chandrasekaran V, Rajkumar RP.
    Asian J Psychiatr; 2018 Mar; 33():68-73. PubMed ID: 29544110
    [Abstract] [Full Text] [Related]

  • 4. The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present.
    Persico AM, Ricciardello A, Lamberti M, Turriziani L, Cucinotta F, Brogna C, Vitiello B, Arango C.
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug 30; 110():110326. PubMed ID: 33857522
    [Abstract] [Full Text] [Related]

  • 5. Psychopharmacological interventions in autism spectrum disorder.
    Accordino RE, Kidd C, Politte LC, Henry CA, McDougle CJ.
    Expert Opin Pharmacother; 2016 Aug 30; 17(7):937-52. PubMed ID: 26891879
    [Abstract] [Full Text] [Related]

  • 6. Effects of Yokukansan, a Japanese Kampo Medicine for Symptoms Associated Autism Spectrum Disorder.
    Wake R, Miyaoka T, Furuya M, Hashioka S, Horiguchi J.
    CNS Neurol Disord Drug Targets; 2016 Aug 30; 15(5):551-63. PubMed ID: 27071791
    [Abstract] [Full Text] [Related]

  • 7. Mood Stabilizers in Children and Adolescents With Autism Spectrum Disorders.
    Canitano R.
    Clin Neuropharmacol; 2015 Aug 30; 38(5):177-82. PubMed ID: 26366961
    [Abstract] [Full Text] [Related]

  • 8. Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review.
    Jobski K, Höfer J, Hoffmann F, Bachmann C.
    Acta Psychiatr Scand; 2017 Jan 30; 135(1):8-28. PubMed ID: 27624381
    [Abstract] [Full Text] [Related]

  • 9. Adaptation of Diagnosis from Autism Spectrum Disorder to Social Communication Disorder in Adolescents with ADHD.
    Tsai LH, Lin JW.
    J Autism Dev Disord; 2020 Feb 30; 50(2):685-687. PubMed ID: 31650372
    [Abstract] [Full Text] [Related]

  • 10. Autism spectrum disorders and their treatment with psychotropic medications in a nationally representative outpatient sample: 1994-2009.
    Kamimura-Nishimura K, Froehlich T, Chirdkiatgumchai V, Adams R, Fredstrom B, Manning P.
    Ann Epidemiol; 2017 Jul 30; 27(7):448-453.e1. PubMed ID: 28789776
    [Abstract] [Full Text] [Related]

  • 11. ADHD severity as it relates to comorbid psychiatric symptomatology in children with Autism Spectrum Disorders (ASD).
    Mansour R, Dovi AT, Lane DM, Loveland KA, Pearson DA.
    Res Dev Disabil; 2017 Jan 30; 60():52-64. PubMed ID: 27889487
    [Abstract] [Full Text] [Related]

  • 12. Pharmacotherapy of emotional and behavioral symptoms associated with autism spectrum disorder in children and adolescents.
    Stepanova E, Dowling S, Phelps M, Findling RL.
    Dialogues Clin Neurosci; 2017 Dec 30; 19(4):395-402. PubMed ID: 29398934
    [Abstract] [Full Text] [Related]

  • 13. Retracing our steps: A review on autism research in children, its limitation and impending pharmacological interventions.
    Salloum-Asfar S, Zawia N, Abdulla SA.
    Pharmacol Ther; 2024 Jan 30; 253():108564. PubMed ID: 38008401
    [Abstract] [Full Text] [Related]

  • 14. Autism Spectrum Disorder: A Review.
    Hirota T, King BH.
    JAMA; 2023 Jan 10; 329(2):157-168. PubMed ID: 36625807
    [Abstract] [Full Text] [Related]

  • 15. Effects of a Nonwearable Digital Therapeutic Intervention on Preschoolers With Autism Spectrum Disorder in China: Open-Label Randomized Controlled Trial.
    Chu L, Shen L, Ma C, Chen J, Tian Y, Zhang C, Gong Z, Li M, Wang C, Pan L, Zhu P, Wu D, Wang Y, Yu G.
    J Med Internet Res; 2023 Aug 24; 25():e45836. PubMed ID: 37616029
    [Abstract] [Full Text] [Related]

  • 16. Social Communication Questionnaire scoring procedures for autism spectrum disorder and the prevalence of potential social communication disorder in ASD.
    Barnard-Brak L, Richman DM, Chesnut SR, Little TD.
    Sch Psychol Q; 2016 Dec 24; 31(4):522-533. PubMed ID: 27929321
    [Abstract] [Full Text] [Related]

  • 17. Cannabidiol as a suggested candidate for treatment of autism spectrum disorder.
    Poleg S, Golubchik P, Offen D, Weizman A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar 08; 89():90-96. PubMed ID: 30171992
    [Abstract] [Full Text] [Related]

  • 18. An update on pharmacotherapy of autism spectrum disorder in children and adolescents.
    Goel R, Hong JS, Findling RL, Ji NY.
    Int Rev Psychiatry; 2018 Feb 08; 30(1):78-95. PubMed ID: 29693461
    [Abstract] [Full Text] [Related]

  • 19. Psychopharmacological interventions in autism spectrum disorder.
    Politte LC, Henry CA, McDougle CJ.
    Harv Rev Psychiatry; 2014 Feb 08; 22(2):76-92. PubMed ID: 24614763
    [Abstract] [Full Text] [Related]

  • 20. Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions.
    Lacivita E, Perrone R, Margari L, Leopoldo M.
    J Med Chem; 2017 Nov 22; 60(22):9114-9141. PubMed ID: 29039668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 100.